Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AKT3 |
| Upstream (Parents) |
|---|
| (<<) DKK3 → AKT3 |
| (<<) ISLR → AKT3 |
| (<<) SPARC → AKT3 |
| Downstream (Children) |
|---|
| AKT3 → LBH (>>) |
| AKT3 → LEPREL1 (>>) |
| AKT3 → CHRNB4 (>>) |
| AKT3 → FHL5 (>>) |
| AKT3 → TMOD2 (>>) |
| AKT3 → OR10C1 (>>) |
| AKT3 → NAP1L3 (>>) |
| AKT3 → RPS8P10///RPS8 (>>) |
| AKT3 → ADAM18 (>>) |
| AKT3 → SLCO2A1 (>>) |
| AKT3 → ITGA8 (>>) |
| AKT3 → STK10 (>>) |
